QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.
about
Comparison of the interferon-gamma release assay with the traditional methods for detecting Mycobacterium tuberculosis infection in childrenA cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in IndiaCost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.Tuberculosis screening of new hospital employees: compliance, clearance to work time, and cost using tuberculin skin test and interferon-gamma release assays.The effectiveness of screening with interferon-gamma release assays in a university health care setting with a diverse global population.Clinical value of a whole blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection during antitubercular treatment.Cost-effectiveness of using Quantiferon Gold (QFT-G)® versus tuberculin skin test (TST) among U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
P2860
Q36193426-CA630CDC-2806-4380-90BE-2293A7BA0001Q36337142-45D78315-1D0F-405D-A864-F0B4FC4C205EQ37192288-F9229FFB-A312-46C0-BE0B-3F8F45E1C597Q37478715-FA5F840F-25F9-4C80-B213-F60FCAFB1E23Q40208853-F8590B6D-7F12-4C08-A467-C8F8BB07B4FBQ40221251-5E00DC6F-210D-47BC-9156-ABC9AF55FE73Q41593849-9A04C6DB-2592-402E-9744-7320E15A97CBQ42963203-DFDA6C66-8C07-4EF4-B347-9D27E89E08A2Q43652113-76A7956D-A341-4931-9B31-A84AA78965D5Q54237978-71068E41-17B4-4765-9ADC-4BDAD2A8E778
P2860
QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@ast
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@en
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@nl
type
label
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@ast
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@en
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@nl
prefLabel
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@ast
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@en
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@nl
P2093
P2860
P356
P1476
QuantiFERON-TB gold in-tube im ...... a cost-effectiveness analysis.
@en
P2093
Danielle DiPietro
Howard Choi
Kathryn Miele
Maria Martins-Evora
Maunank Shah
Susan Dorman
Vincent Marsiglia
P2860
P2888
P356
10.1186/1471-2334-12-360
P577
2012-12-19T00:00:00Z